Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
One should avoid trading aggressively till the time market stabilises from this turbulence, Sameet Chavan of Angel One advises
Sudarshan Sukhani of s2analytics.com recommends buying Cadila Healthcare with stop loss at Rs 264 and target of Rs 279 and Colgate Palmolive with stop loss at Rs 1490 and target of Rs 1535.
Sudarshan Sukhani of s2analytics.com advises buying Asian Paint with stop loss at Rs 1,760 and target of Rs 1,820.
We are seeing indications of short term up move in select PSU banks but we still recommend preferring private banks over the PSU pack for the long term investment.
Earnings growth for FY20 will get better by H2FY20 led by positive lag-effect of reforms,” says Vinod Nair, Head Of Research at Geojit Financial Services
Credit Suisse maintained its underperform rating on Lupin with a target price of Rs 800 while CLSA maintained its sell rating on Ashok Leyland and slashed its target price to Rs 75 from Rs 85 earlier.
Sudarshan Sukhani of s2analytics.com recommends buying Bata India with stop loss at Rs 1145 and target of Rs 1170, Berger Paints with stop loss at Rs 322 and target of Rs 331 and HCL Tech with stop loss at Rs 955 and target of Rs 980.
Ashwani Gujral of ashwanigujral.com is of the view that one can sell Tata Steel, Adani Enterprises, JSW Steel and Vedanta and can buy L&T Finance and Piramal Enterprises.
Ashwani Gujral of ashwanigujral.com is of the view that one can sell Canara Bank and Punjab National Bank and can buy Ashok Leyland.
Prakash Gaba of prakashgaba.com recommends buying Cummins India, Lupin, PVR and Camlin Fine Sciences.
Rajat Bose of rajatkbose.com is of the view that one may buy Lupin, Vedanta and Voltas.
Mitessh Thakkar of miteshthacker.com suggests selling L&T and CESC.
In an interview to CNBC-TV18's Latha Venkatesh, Surabhi Upadhyay and Anuj Singhal, SP Tulsian of sptulsian.com shared his reading and outlook on the market and also gave recommendations on various stocks.
Rahul Shah, Associate VP of Motilal Oswal advises buying Tata Chemicals, Punjab National Bank, Lupin and Tata Motors.
Chandan Taparia of Motilal Oswal Securities suggests buying L&T Finance and Hexaware Technologies and advises trading Bull Call Spread in Coal India.
In an interview to CNBC-TV18's Anuj Singhal and Surabhi Upadhyay, SP Tulsian of sptulsian.com shared his views and outlook on the fundamentals of the market and specific stocks.
Ashwani Gujral of ashwanigujral.com suggests buying UPL, DCB Bank and L&T Finance.
Sun Pharma is n focus after Taro, its US arm, reports a 30 percent decline in net sales. In an interview to CNBC-TV18, Amey Chalke, Research Analyst at HDFC Securities shared his readings and outlook on the same as well as on some other pharma stocks.
Ashwani Gujral of ashwanigujral.com is of the view that one can buy Colgate Palmolive and Godrej Consumer and sell Dr Reddy's Labs and Lupin.